Ultragenyx Pharmaceutical (RARE)'s 30-day implied volatility (IV30) was 63.3% at the close on October 30, 2026, up from 46.0% the day before, against a 52-week range of 30.9% to 183.2%. Its 20-day historical volatility was 51.4%.
Data as of October 30, 2026.